Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.

Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.

Tuberculosis (TB) continues to be a major global health disaster, despite the widespread use of BCG and effective drug therapies. The development of an efficacious new TB vaccine would be an important component of disease control in the future. Many approaches are being utilised to enhance understan...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Sander, C, Mcshane, H
Format:	Journal article
Język:	English
Wydane:	2007

Podobne zapisy

Developing an improved vaccine against tuberculosis.
od: Mcshane, H
Wydane: (2004)

Vaccine strategies against tuberculosis.
od: Mcshane, H
Wydane: (2009)

Vaccine strategies against tuberculosis
od: H McShane
Wydane: (2009-03-01)

Vaccines for tuberculosis
od: McShane, H
Wydane: (2013)

Insights and challenges in tuberculosis vaccine development
od: McShane, H
Wydane: (2019)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
od: Fletcher, H, i wsp.
Wydane: (2009)

Tuberculosis vaccines in clinical trials.
od: Rowland, R, i wsp.
Wydane: (2011)

Tuberculosis vaccines: progress and challenges.
od: Checkley, A, i wsp.
Wydane: (2011)

Tuberculosis vaccines: present and future.
od: Minassian, A, i wsp.
Wydane: (2008)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
od: McShane, H
Wydane: (2023)

Vaccination against tuberculosis: how can we better BCG?
od: Pitt, J, i wsp.
Wydane: (2013)

Vaccination against tuberculosis: How can we better BCG?
od: Pitt, J, i wsp.
Wydane: (2013)

Tuberculosis vaccines: Progress and challenges
od: Checkley, A, i wsp.
Wydane: (2011)

Tuberculosis vaccine promises sterilizing immunity.
od: Mcshane, H, i wsp.
Wydane: (2011)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
od: McShane, H
Wydane: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
od: McShane, H
Wydane: (2011)

Tuberculosis vaccines: current status and future prospects.
od: Fletcher, H, i wsp.
Wydane: (2006)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle.
od: Villarreal-Ramos, B, i wsp.
Wydane: (2014)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
od: Villarreal-Ramos, B, i wsp.
Wydane: (2014)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
od: Vermaak, S, i wsp.
Wydane: (2023)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
od: Hopkins, R, i wsp.
Wydane: (2011)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
od: Villarreal-Ramos, B, i wsp.
Wydane: (2017)

Clinical testing of tuberculosis vaccine candidates
od: Hatherill, M, i wsp.
Wydane: (2016)

WHO preferred product characteristics for new vaccines against tuberculosis
od: Schrager, L, i wsp.
Wydane: (2018)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
od: Vordermeier, H, i wsp.
Wydane: (2009)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
od: Richard Hopkins, i wsp.
Wydane: (2011-01-01)

Development of a primate model for tuberculosis vaccine research: IFN-gamma responses induced by BCG vaccination and M-tuberculosis infection in macaques
od: Dowall, S, i wsp.
Wydane: (2007)

Identification of antigens presented by MHC for vaccines against tuberculosis
od: Bettencourt, P, i wsp.
Wydane: (2020)

Mini review on Potency Evaluation of Rabies Vaccine preparations
od: Walaa Rashed, i wsp.
Wydane: (2021-12-01)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A.
od: de Cassan, S, i wsp.
Wydane: (2010)

Why don’t we have an effective tuberculosis vaccine yet?
od: Davenne, T, i wsp.
Wydane: (2016)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
od: Griffiths, K, i wsp.
Wydane: (2013)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
od: Stylianou, E, i wsp.
Wydane: (2019)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
od: Mcshane, H, i wsp.
Wydane: (2016)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
od: Vordermeier, H, i wsp.
Wydane: (2011)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
od: Mcshane, H, i wsp.
Wydane: (2005)

Identification of antigens presented by MHC for vaccines against tuberculosis
od: Bettencourt, P, i wsp.
Wydane: (2020)

ON VACCINATION OF ADOLESCENTS AGAINST TUBERCULOSIS
od: L. A. Zazimko, i wsp.
Wydane: (2014-01-01)

Reactive arthritis after vaccination against SARS-CoV-2: A case series and a mini-review
od: Wiktoria Wojturska, i wsp.
Wydane: (2023-01-01)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG immunized adults vaccinated with a new tuberculosis vaccine, MVA85A (Clinical and Vaccine Immunology (2010) 17, 7, (1066-1073))
od: De Cassan, S, i wsp.
Wydane: (2011)